Literature DB >> 7497145

Effect of retesting with dietary restriction in Haemoccult screening for colorectal cancer.

M H Robinson1, S M Moss, J D Hardcastle, D K Whynes, J O Chamberlain, C M Mangham.   

Abstract

OBJECTIVES: To determine the detection rate, false positive and false negative rates associated with a policy of retesting with dietary restriction after an initial positive Haemoccult screening test for colorectal cancer, in order to compare the cost effectiveness of such a policy with the alternative, in which all subjects with a positive test would proceed directly to diagnostic colonoscopy.
METHODS: Over four years in a large randomised control trial in Nottingham 35,260 subjects had a mean of 1.5 screening rounds each at two-yearly intervals, and were followed up for a minimum of 27 months. During this period subjects with positive screening tests were asked to repeat the test with dietary restrictions. Estimates of costs of the initial screening and of diagnostic colonoscopy were used to estimate the cost for each cancer detected by the different policies.
RESULTS: 1209 subjects had a positive initial screening test and 1033 (85.4%) completed the retests. Four hundred and ninety nine subjects were investigated and 89 cancers detected. In the 710 subjects with negative retests six interval cancers were diagnosed in the two years after screening. If these had been detected by screening under a policy of immediate colonoscopy, test sensitivity would have been improved from 53.6% to 57.2% (P = 0.02), but the cost for each cancer detected would have increased from pound 773 to pound 1509.
CONCLUSION: Retesting with dietary restrictions reduces costs and maximises the benefit of limited colonoscopy resources, but results in a small but significant reduction in test sensitivity compared with a policy for immediate colonoscopy.

Entities:  

Mesh:

Year:  1995        PMID: 7497145     DOI: 10.1177/096914139500200111

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  5 in total

1.  Detection rate of immunochemical fecal occult blood test for colorectal adenomatous polyps with severe dysplasia.

Authors:  H Nakama; A S Abdul Fattah; B Zhang; N Kamijo; K Fujimori; K Miyata
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 2.  Dietary interventions for fecal occult blood test screening: systematic review of the literature.

Authors:  Gerald Konrad
Journal:  Can Fam Physician       Date:  2010-03       Impact factor: 3.275

3.  Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review.

Authors:  Neeraj Narula; Diana Ulic; Raed Al-Dabbagh; Ali Ibrahim; Maged Mansour; Cynthia Balion; John K Marshall
Journal:  Can J Gastroenterol Hepatol       Date:  2014-07-11

4.  Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: the experience of the Department of Calvados (France).

Authors:  V Bouvier; G Launoy; C Herbert; H Lefevre; J Maurel; M Gignoux
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

5.  Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm.

Authors:  Benjamin Kearns; Sophie Whyte; Helen E Seaman; Julia Snowball; Stephen P Halloran; Piers Butler; Julietta Patnick; Claire Nickerson; Jim Chilcott
Journal:  Br J Cancer       Date:  2016-01-14       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.